Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever
about
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymeraseBroad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverProgress in the experimental therapy of severe arenaviral infectionsEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverFavipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic feverFavipiravir: a new medication for the Ebola virus disease pandemic.Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.Favipiravir (T-705), a novel viral RNA polymerase inhibitor.Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to manThe broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever virusesIn Vitro Assessment of Combinations of Enterovirus Inhibitors against Enterovirus 71Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.Animal models, prophylaxis, and therapeutics for arenavirus infections.Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.Current drug discovery strategies against arenavirus infections.Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.Ebola virus disease: societal challenges and new treatments.Broad-spectrum antiviral agents.Extinction of West Nile virus by Favipiravir through lethal mutagenesis.Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Favipiravir elicits antiviral mutagenesis during virus replication in vivo.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.
P2860
Q21089768-73E430D1-7263-4F8C-8C35-DEB2D57D5828Q21092271-C7F038AE-4B0C-4B99-BAEC-810CDCAF19C4Q27024953-A55F1C47-D554-48A5-A57F-946C62B1326DQ27457152-239E959A-2444-4708-8EFE-34F15E2CE1CFQ28537976-E4BFEC97-00BD-461F-BA95-F84B7E9930B3Q30370190-A26A4650-814E-4468-A3C7-45304296759BQ33825147-0AD7B0CE-3DAC-4F16-8127-2B3CC26A5D3DQ34374652-A4AEFE04-D393-45BC-A9A2-8F294A13D5CCQ35248863-FFA9BCB6-4B88-4AC2-9C56-223688EAB4F5Q36146469-AA2E347C-81A9-4BED-A882-B8FC9906369CQ36166222-69FBDBDF-A8CA-4AE3-B592-19A4BDCE406FQ36494323-B40DBEF6-FEC8-42E8-B427-2D264285615DQ37203766-3A47DE51-3E60-4BE4-A361-D02AD90E3E09Q37263923-FE034C3D-5ACC-44BB-AE29-6E3ABD593F96Q38061427-593A0EF7-F1DB-4C26-8DE8-24973D42F9FFQ38064285-39435AED-4A12-4B46-85D1-046ED6E8587CQ38067504-AC71B4BC-8D21-4757-93AB-9AAFC899954EQ38069359-E86CA12F-B58C-4A1A-B156-1F5C199FEF2CQ38388679-6AA3BFCB-8425-4ADA-88F8-0F63FE4B735EQ38519881-E7965C71-B208-49A3-ADD7-5E8163817A63Q38605122-5F083AD0-BC37-4079-ABBB-62115A904092Q38638782-01F069BA-EA21-40A1-AFCD-3A71FF9AA8DEQ38833628-0F55A865-FCEC-469C-AB7B-B746BF19E1C4Q40044875-B9DEFFC2-50FE-4121-828A-486306E67E35Q41693281-17C1710C-AA5E-4423-8443-AC16F3B68A74Q45324172-AEAEBFE2-D751-417B-8045-2EBF3CCB386CQ52723914-DD3F0489-E55B-4731-842E-40E41E3A0C7E
P2860
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@ast
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@en
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@nl
type
label
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@ast
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@en
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@nl
prefLabel
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@ast
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@en
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@nl
P2093
P2860
P3181
P1476
Effective oral favipiravir (T- ...... f arenavirus hemorrhagic Fever
@en
P2093
Andrew Russell
Brian B Gowen
Jeffery O Hall
Michelle Mendenhall
Ramona Skirpstunas
Yousuke Furuta
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0001342
P407
P577
2011-10-01T00:00:00Z